Background illustration for clinical trials search

Paid Clinical Trials St. Louis

Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

for
Chronic Lymphocytic Leukemia, CLL, Mantle Cell Lymphoma, MCL
Location: St Louis MO, Westwood KS, Fort Wayne IN, Tampa FL,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06697184

Phase1, Phase2, Recruiting

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

for
Small-cell Lung Cancer, Small Cell Lung Cancer Extensive Stage
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07545954

Phase1, Recruiting

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

for
Multiple Sclerosis (MS) - Relapsing-remitting
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 40 - 70

Code: NCT07758270

Recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

for
Pulmonary Arterial Hypertension
Location: St Louis MO, Kansas City KS, Louisville KY, Chicago IL,
Sponsor: Gossamer Bio USA, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06274801

Phase3, Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

for
Carcinoma, Renal Cell
Location: St Louis MO, Germantown TN, Marietta GA, New York NY
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07489495

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: St Louis MO, Knoxville TN, Atlanta GA, Duarte CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07544654

Phase3, Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,
Location: St Louis MO, O'Fallon IL, Centralia IL, Springfield IL,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05256225

Phase3, Recruiting

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

for
Metastatic Malignant Solid Neoplasm,
Location: St Louis MO, Chicago IL, Madison WI, Lexington KY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05372614

Phase1, Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

for
Acute Adult T-Cell Leukemia/Lymphoma,
Location: St Louis MO, Creve Coeur MO, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04301076

Phase1, Recruiting

Depression and Driving

for
Depression, Drive
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 65+

Code: NCT05446805

Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: St Louis MO, Chicago IL, Columbus OH, Birmingham AL,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase2, Recruiting

Rivastigmine for Antimuscarinic Delirium

for
Anticholinergic Toxicity
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 10+

Code: NCT06382649

Phase2, Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

for
Meningioma
Location: St Louis MO, Madison WI, Rochester NY, Columbus OH,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07428616

Phase2, Recruiting

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

for
Pancreatic Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06141031

Phase1, Recruiting

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer,
Location: St Louis MO, Nashville TN, Greenville SC, Dallas TX,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18+

Code: NCT07545811

Phase1, Recruiting

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

for
Pancreatic Adenocarcinoma, Cancer of the Pancreas,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07126158

Phase2, Recruiting

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

for
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD,
Location: St Louis MO, Little Rock AR
Sponsor: Precision BioSciences, Inc.

Sex: Male

Age: 2 - 7

Code: NCT07429240

Phase1, Phase2, Recruiting

CARE Tool Study Aim 3

for
Gynecologic Cancer, Prostate Cancer, Lung Cancer,
Location: St Louis MO, Alton IL, Rolla MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07296887

Recruiting

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

for
Depressive Disorder, Major,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 65

Code: NCT02994433

Phase1, Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

for
Lymphoma
Location: St Louis MO, Nashville TN, Chicago IL, Columbus OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT07015242

Phase2, Recruiting